Hyphens Pharma International Ltd
SGX:1J5
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.265
0.3
|
Price Target |
|
We'll email you a reminder when the closing price reaches SGD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one 1J5 stock under the Base Case scenario is 0.53 SGD. Compared to the current market price of 0.285 SGD, Hyphens Pharma International Ltd is Undervalued by 46%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Hyphens Pharma International Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for 1J5 cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Hyphens Pharma International Ltd
Balance Sheet Decomposition
Hyphens Pharma International Ltd
Current Assets | 101.6m |
Cash & Short-Term Investments | 18.8m |
Receivables | 46m |
Other Current Assets | 36.8m |
Non-Current Assets | 30.2m |
PP&E | 5.1m |
Intangibles | 24.9m |
Other Non-Current Assets | 213k |
Current Liabilities | 57.7m |
Accounts Payable | 50.4m |
Other Current Liabilities | 7.2m |
Non-Current Liabilities | 8.2m |
Long-Term Debt | 3.8m |
Other Non-Current Liabilities | 4.4m |
Earnings Waterfall
Hyphens Pharma International Ltd
Revenue
|
195.5m
SGD
|
Cost of Revenue
|
-126.9m
SGD
|
Gross Profit
|
68.7m
SGD
|
Operating Expenses
|
-51.7m
SGD
|
Operating Income
|
17m
SGD
|
Other Expenses
|
-6.6m
SGD
|
Net Income
|
10.4m
SGD
|
Free Cash Flow Analysis
Hyphens Pharma International Ltd
SGD | |
Free Cash Flow | SGD |
1J5 Profitability Score
Profitability Due Diligence
Hyphens Pharma International Ltd's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
Score
Hyphens Pharma International Ltd's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
1J5 Solvency Score
Solvency Due Diligence
Hyphens Pharma International Ltd's solvency score is 82/100. The higher the solvency score, the more solvent the company is.
Score
Hyphens Pharma International Ltd's solvency score is 82/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
1J5 Price Targets Summary
Hyphens Pharma International Ltd
According to Wall Street analysts, the average 1-year price target for 1J5 is 0.383 SGD with a low forecast of 0.354 SGD and a high forecast of 0.42 SGD.
Dividends
Current shareholder yield for 1J5 is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Hyphens Pharma International Ltd. is an investment holding company, which engages in the provision of specialty pharmaceutical and consumer healthcare products. The firm's principal activities are those of an investment holding company and provision of management services. The firm's segments include specialty pharma principals, proprietary brands, and medical hypermart and digital. The specialty pharma principals segment is engaged in the business of marketing and selling a range of specialty pharmaceutical products with exclusivity in the relevant ASEAN countries. The proprietary brands segment is engaged in the business of developing, marketing and selling its own proprietary range of dermatological products and health supplement products. The medical hypermart and digital segment is a wholesaler of pharmaceuticals and medical supplies in Singapore, which the Company and its subsidiaries position itself as a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies.
Officers
The intrinsic value of one 1J5 stock under the Base Case scenario is 0.53 SGD.
Compared to the current market price of 0.285 SGD, Hyphens Pharma International Ltd is Undervalued by 46%.